Mosterd, A. & Hoes, A. W. Clinical epidemiology of heart failure. Heart 93, 1137–1146 (2007).ArticleÂ
Google ScholarÂ
Tomasoni, D., Adamo, M., Lombardi, C. M. & Metra, M. Highlights in heart failure. ESC Heart Fail. 6, 1105–1127 (2020).ArticleÂ
Google ScholarÂ
Koene, R. J., Prizment, A. E., Blaes, A. & Konety, S. H. Shared risk factors in cardiovascular disease and cancer. Circulation 133, 1104–1114 (2016).ArticleÂ
Google ScholarÂ
de Wit, S., Glen, C., de Boer, R. A. & Lang, N. N. Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies. Cardiovasc. Res. 118, 3451–3466 (2022).ArticleÂ
Google ScholarÂ
Gröschel, C. et al. CD8+-T cells with specificity for a model antigen in cardiomyocytes can become activated after transverse aortic constriction but do not accelerate progression to heart failure. Front. Immunol. 9, 2665 (2018).ArticleÂ
Google ScholarÂ
Aghajanian, H. et al. Targeting cardiac fibrosis with engineered T cells. Nature 573, 430–433 (2019).ArticleÂ
ADSÂ
CASÂ
Google ScholarÂ
Komai, K. et al. Single-cell analysis revealed the role of CD8+ effector T cells in preventing cardioprotective macrophage differentiation in the early phase of heart failure. Front. Immunol. 12, 763647 (2021).ArticleÂ
CASÂ
Google ScholarÂ
Laroumanie, F. et al. CD4+T cells promote the transition from hypertrophy to heart failure during chronic pressure overload. Circulation 129, 2111–2124 (2014).ArticleÂ
CASÂ
Google ScholarÂ
Zhao, S., Wu, Y., Wei, Y., Xu, X. & Zheng, J. Identification of biomarkers associated with CD8+ T cells in coronary artery disease and their pan-cancer analysis. Front. Immunol. 13, 876616 (2022).ArticleÂ
CASÂ
Google ScholarÂ
Tsukumo, S. I. & Yasutomo, K. Regulation of CD8+ T cells and antitumor immunity by notch signaling. Front. Immunol. 30, 9 (2018).
Google ScholarÂ
Kersten, K. et al. Spatiotemporal co-dependency between macrophages and exhausted CD8+ T cells in cancer. Cancer Cell 40, 624–638 (2022).ArticleÂ
CASÂ
Google ScholarÂ
Gutiérrez-Melo, N. & Baumjohann, D. T follicular helper cells in cancer. Trends Cancer 9, 309–325 (2023).ArticleÂ
Google ScholarÂ
Langfelder, P. & Horvath, S. WGCNA: An R package for weighted correlation network analysis. BMC Bioinf. 9, 559 (2008).ArticleÂ
Google ScholarÂ
Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12, 453–457 (2015).ArticleÂ
CASÂ
Google ScholarÂ
Zhu, J., Meng, H., Zhang, L. & Li, Y. Exploring the molecular mechanism of comorbidity of autism spectrum disorder and inflammatory bowel disease by combining multiple data sets. J. Transl. Med. 21, 372 (2023).ArticleÂ
CASÂ
Google ScholarÂ
Wang, M. et al. Transcriptomic analysis of asthma and allergic rhinitis reveals CST1 as a biomarker of unified airways. Front. Immunol. 14, 1048195 (2023).ArticleÂ
CASÂ
Google ScholarÂ
Obuchowski, N. A. & Bullen, J. A. Receiver operating characteristic (ROC) curves: review of methods with applications in diagnostic medicine. Phys. Med. Biol. 63, 07TR01 (2018).ArticleÂ
Google ScholarÂ
Sui, Q. et al. Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer. Nat. Commun. 13, 7316 (2022).ArticleÂ
ADSÂ
CASÂ
Google ScholarÂ
Sargent, D. J. et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J. Clin. Oncol. 28, 3219–3226 (2010).ArticleÂ
CASÂ
Google ScholarÂ
Goldman, M. J. et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat. Biotechnol. 38, 675–678 (2020).ArticleÂ
CASÂ
Google ScholarÂ
Thorsson, V. et al. The immune landscape of cancer. Immunity 48, 812-830.e814 (2018).ArticleÂ
CASÂ
Google ScholarÂ
Hong, M., Clubb, J. D. & Chen, Y. Y. Engineering CAR-T Cells for next-generation cancer therapy. Cancer Cell 38, 473–488 (2020).ArticleÂ
CASÂ
Google ScholarÂ
Balko, J. et al. T cells specific for α-myosin drive immunotherapy-related myocarditis. Nature 611, 818–826 (2022).ArticleÂ
ADSÂ
Google ScholarÂ
Läubli, H. et al. Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma. J. Immunother. Cancer 3, 11 (2015).ArticleÂ
Google ScholarÂ
Sur, M. et al. Transgenic mice expressing functional TCRs specific to cardiac Myhc-α 334–352 on both CD4 and CD8 T cells are resistant to the development of myocarditis on C57BL/6 genetic background. Cells 12, 2346 (2023).ArticleÂ
CASÂ
Google ScholarÂ
Meijers, W. C. & de Boer, R. A. Common risk factors for heart failure and cancer. Cardiovasc. Res. 115, 844–853 (2019).ArticleÂ
CASÂ
Google ScholarÂ
Kachanova, O., Lobov, A. & Malashicheva, A. The role of the notch signaling pathway in recovery of cardiac function after myocardial infarction. Int. J. Mol. Sci. 23, 12509 (2022).ArticleÂ
CASÂ
Google ScholarÂ
Aoyagi, T. & Matsui, T. Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failure. Curr. Pharm. Des. 17, 1818–1824 (2011).ArticleÂ
CASÂ
Google ScholarÂ
Zhong, S. et al. Apelin-13 alleviated cardiac fibrosis via inhibiting the PI3K/Akt pathway to attenuate oxidative stress in rats with myocardial infarction-induced heart failure. Biosci. Rep. 40(4), 20200040 (2020).ArticleÂ
Google ScholarÂ
Hoxhaj, G. & Manning, B. D. The PI3K–AKT network at the interface of oncogenic signalling and cancer metabolism. Nat. Rev. Cancer 20, 74–88 (2019).ArticleÂ
Google ScholarÂ
Ferreira, A. & Aster, J. C. Notch signaling in cancer: Complexity and challenges on the path to clinical translation. Semin. Cancer Biol. 85, 95–106 (2022).ArticleÂ
CASÂ
Google ScholarÂ
Yu, T., Robotham, J. L. & Yoon, Y. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc. Natl. Acad. Sci. 103(8), 2653–2658 (2006).ArticleÂ
ADSÂ
CASÂ
Google ScholarÂ
Yu, H. et al. LARP7 protects against heart failure by enhancing mitochondrial biogenesis. Circulation 143, 2007–2022 (2021).ArticleÂ
CASÂ
Google ScholarÂ
Vyas, S., Zaganjor, E. & Haigis, M. C. Mitochondria and cancer. Cell 166, 555–566 (2016).ArticleÂ
CASÂ
Google ScholarÂ
Turman, M. A., Yabe, T., McSherry, C., Bach, F. H. & Houchins, J. P. Characterization of a novel gene (NKG7) on human chromosome 19 that is expressed in natural killer cells and T cells. Human Immunol. 36(1), 34–40 (1993).ArticleÂ
CASÂ
Google ScholarÂ
Peña, S. V. & Krensky, A. M. Granulysin, a new human cytolytic granule-associated protein with possible involvement in cell-mediated cytotoxicity. Semin Immunol. 9, 117–125 (1997).ArticleÂ
Google ScholarÂ
Wen, T. et al. NKG7 Is a T-cell–intrinsic therapeutic target for improving antitumor cytotoxicity and cancer immunotherapy. Cancer Immunol. Res. 10, 162–181 (2022).ArticleÂ
CASÂ
Google ScholarÂ
Martinez-Lostao, L., Miguel, D. D., Al-Wasaby, S., Gallego-Lleyda, A. & Anel, A. Death ligands and granulysin: mechanisms of tumor cell death induction and therapeutic opportunities. Immunotherapy 7(8), 883–882 (2015).ArticleÂ
Google ScholarÂ
Milovanović, J. et al. Can granulysin provide prognostic value in primary breast cancer?. Pathol. –Res. Pract. 237, 154039 (2022).ArticleÂ
Google ScholarÂ
Pilat, D. et al. The human Met-ase gene (GZMM): structure, sequence, and close physical linkage to the serine protease gene cluster on 19p13.3. Genomics 24(3), 445–450 (1994).ArticleÂ
CASÂ
Google ScholarÂ
Susanto, O., Trapani, J. A. & Brasacchio, D. Controversies in granzyme biology. Tissue Antigens 80, 477–487 (2012).ArticleÂ
CASÂ
Google ScholarÂ
Hu, D. et al. Cleavage of survivin by granzyme M triggers degradation of the survivin-X-linked Inhibitor of apoptosis protein (XIAP) complex to free caspase activity leading to cytolysis of target tumor cells. J. Biol. Chem. 285, 18326–18335 (2010).ArticleÂ
CASÂ
Google ScholarÂ
Cullen, S. P. et al. Nucleophosmin is cleaved and inactivated by the cytotoxic granule protease granzyme M during natural killer cell-mediated Killing. J. Biol. Chem. 284, 5137–5147 (2009).ArticleÂ
CASÂ
Google ScholarÂ
Rai, S. et al. Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma. Cancer Sci. 113, 660–673 (2021).ArticleÂ
Google ScholarÂ
Amin, S., Parker, A. & Mann, J. ZAP70 in chronic lymphocytic leukaemia. Int. J. Biochem. Cell Biol. 40, 1654–1658 (2008).ArticleÂ
CASÂ
Google ScholarÂ
Au-Yeung, B. B. et al. The structure, regulation, and function of ZAP-70. Immunol. Rev. 228, 41–57 (2009).ArticleÂ
CASÂ
Google ScholarÂ
Ashouri, J. F., Lo, W. L., Nguyen, T. T. T., Shen, L. & Weiss, A. ZAP70, too little, too much can lead to autoimmunity. Immunol. Rev. 307, 145–160 (2021).ArticleÂ
Google ScholarÂ
Ren, L., Li, P., Li, Z. & Chen, Q. AQP9 and ZAP70 as immune-related prognostic biomarkers suppress proliferation, migration and invasion of laryngeal cancer cells. BMC Cancer 22 (2022).Song, P. et al. Identification of important genes related to anoikis in acute myocardial infarction. J Cell Mol Med 28 (2024).Dunsmore, K. P. et al. Children’s oncology group AALL0434: A phase III randomized clinical trial testing nelarabine in newly diagnosed T-cell acute lymphoblastic leukemia. J. Clin. Oncol. 38, 3282–3293 (2020).ArticleÂ
CASÂ
Google ScholarÂ
Baritussio, A., Gately, A., Pawade, J., Marks, D. I. & Bucciarelli-Ducci, C. Extensive cardiac infiltration in acute T-cell lymphoblastic leukemia: occult extra-medullary relapse and remission after salvage chemotherapy. Eur. Heart J. 38, 1933 (2016).
Google ScholarÂ
Robichaux, D. J., Harata, M., Murphy, E. & Karch, J. Mitochondrial permeability transition pore-dependent necrosis. J. Mol. Cell. Cardiol. 174, 47–55. https://doi.org/10.1016/j.yjmcc.2022.11.003 (2023).ArticleÂ
CASÂ
Google ScholarÂ
Vagos Mata, A. et al. Chronic lymphocytic leukaemia/small lymphocytic lymphoma treatment with rituximab and high-dose methylprednisolone, revisited. Cancer Med. 10, 8768–8776 (2021).ArticleÂ
CASÂ
Google ScholarÂ
Rovetto, M. J. Effect of hyaluronidase and methylprednisolone on myocardial function, glucose metabolism, and coronary flow in the isolated ischemic rat heart. Circ. Res. 41, 373–379 (1977).ArticleÂ
CASÂ
Google ScholarÂ
Nayler, W. G., Yepez, C., Grau, A. & Slade, A. Protective effect of methylprednisolone sodium succinate on the ultrastructure and resting tension of hypoxic heart muscle. Cardiovasc. Res. 12, 91–98s (1978).ArticleÂ
CASÂ
Google ScholarÂ
Greenberg, B. H. Emerging treatment approaches to improve outcomes in patients with heart failure. Cardiol. Discov. 4, 231–240 (2022).ArticleÂ
Google ScholarÂ
Huang, Y. et al. The protective role of Yin-Yang 1 in cardiac injury and remodeling after myocardial infarction. J. Am. Heart Assoc. 10, e021895 (2021).ArticleÂ
CASÂ
Google ScholarÂ
Cho, A. A. & Bonavida, B. Targeting the overexpressed YY1 in cancer inhibits EMT and metastasis. Crit. Rev. Oncog. 22, 49–61 (2017).ArticleÂ
Google ScholarÂ
Chen, S. et al. YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6. J Immunother Cancer 11, e006020 (2023).ArticleÂ
Google ScholarÂ
Thomassen, M., Tan, Q. & Kruse, T. A. Gene expression meta-analysis identifies metastatic pathways and transcription factors in breast cancer. BMC Cancer 8, 394 (2008).ArticleÂ
Google ScholarÂ
Krensky, A. M. & Clayberger, C. Granulysin: A novel host defense molecule. Am. J. Transpl. 5, 1789–1792 (2005).ArticleÂ
CASÂ
Google ScholarÂ
Flam, E. et al. Integrated landscape of cardiac metabolism in end-stage human nonischemic dilated cardiomyopathy. Nat. Cardiovasc. Res. 1, 817–829 (2022).
Google ScholarÂ
Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucl. Acids Res. 43, e47–e47 (2015).ArticleÂ
Google ScholarÂ
Yu, G., Wang, L.-G., Han, Y. & He, Q.-Y. clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS 16, 284–287 (2012).ArticleÂ
CASÂ
Google ScholarÂ
Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucl. Acids Res. 28, 27–30 (2000).ArticleÂ
CASÂ
Google ScholarÂ
Chen, B., Khodadoust, M. S., Liu, C. L., Newman, A. M. & Alizadeh, A. A. in Methods Mol Biol Methods in Molecular Biology Ch. Chapter 12, 243–259 (2018).Miao, Y. et al. Prognostic value and immunological role of PDCD1 gene in pan-cancer. Int. Immunopharmacol. 89, 107080 (2020).ArticleÂ
CASÂ
Google ScholarÂ
Shankavaram, U. T. et al. Cell Miner: A relational database and query tool for the NCI-60 cancer cell lines. BMC Genomics 10, 277 (2009).ArticleÂ
Google ScholarÂ
Tang, Z., Kang, B., Li, C., Chen, T. & Zhang, Z. GEPIA2: An enhanced web server for large-scale expression profiling and interactive analysis. Nucl. Acids Res. 47, W556–W560 (2019).ArticleÂ
CASÂ
Google ScholarÂ
Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013).ArticleÂ
ADSÂ
Google ScholarÂ
Liu, J. et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell 173, 400-416.e411 (2018).ArticleÂ
CASÂ
Google ScholarÂ
Kumar, M., Kumar, R., Singhal, N. & Garg, A. mRNALoc: A novel machine-learning based in-silico tool to predict mRNA subcellular localization. Nucl. Acids Res. 48, W239–W243 (2020).ArticleÂ
Google ScholarÂ
Xia, J., Gill, E. E. & Hancock, R. E. W. NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data. Nat. Protoc. 10, 823–844 (2015).ArticleÂ
CASÂ
Google ScholarÂ
Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545–15550 (2005).ArticleÂ
ADSÂ
CASÂ
Google ScholarÂ
Reinhold, W. C. et al. Cell miner: A web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. Cancer Res. 72, 3499–3511 (2012).ArticleÂ
CASÂ
Google ScholarÂ